These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 6619578)

  • 1. Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers.
    Samo TC; Greenberg SB; Couch RB; Quarles J; Johnson PE; Hook S; Harmon MW
    J Infect Dis; 1983 Sep; 148(3):535-42. PubMed ID: 6619578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-based agents for current and future viral respiratory infections: A scoping literature review of human studies.
    Mesic A; Jackson EK; Lalika M; Koelle DM; Patel RC
    PLOS Glob Public Health; 2022; 2(4):e0000231. PubMed ID: 36962150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds.
    Radanovic I; Klarenbeek N; Rissmann R; Groeneveld GJ; van Brummelen EMJ; Moerland M; Bosch JJ
    Front Oncol; 2022; 12():954806. PubMed ID: 36106110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities.
    Matos ADR; Wunderlich K; Schloer S; Schughart K; Geffers R; Seders M; Witt M; Christersson A; Wiewrodt R; Wiebe K; Barth P; Hocke A; Hippenstiel S; Hönzke K; Dittmer U; Sutter K; Rescher U; Rodionycheva S; Matera N; Ludwig S; Brunotte L
    Emerg Microbes Infect; 2019; 8(1):1763-1776. PubMed ID: 31826721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
    Velkov T; Abdul Rahim N; Zhou QT; Chan HK; Li J
    Adv Drug Deliv Rev; 2015 May; 85():65-82. PubMed ID: 25446140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.
    Rollinger JM; Schmidtke M
    Med Res Rev; 2011 Jan; 31(1):42-92. PubMed ID: 19714577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
    Couch RB; Atmar RL; Cate TR; Quarles JM; Keitel WA; Arden NH; Wells J; Niño D; Wyde PR
    Vaccine; 2009 Aug; 27(39):5344-8. PubMed ID: 19607949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial strategies: an option to treat allergy?
    Papadopoulos NG; Konstantinou GN
    Biomed Pharmacother; 2007 Jan; 61(1):21-8. PubMed ID: 17188832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatment regimes for virus-induced exacerbations of asthma.
    Edwards MR; Kebadze T; Johnson MW; Johnston SL
    Pulm Pharmacol Ther; 2006; 19(5):320-34. PubMed ID: 16289761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of clinical illness in hospitalized patients with "common cold" virus infections.
    El-Sahly HM; Atmar RL; Glezen WP; Greenberg SB
    Clin Infect Dis; 2000 Jul; 31(1):96-100. PubMed ID: 10913403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the common cold.
    Mossad SB
    BMJ; 1998 Jul; 317(7150):33-6. PubMed ID: 9651268
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology, pathogenesis, and treatment of the common cold.
    Turner RB
    Ann Allergy Asthma Immunol; 1997 Jun; 78(6):531-9; quiz 539-40. PubMed ID: 9207716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The common cold.
    Lorber B
    J Gen Intern Med; 1996 Apr; 11(4):229-36. PubMed ID: 8744881
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferons and viral infections.
    Higgins PG
    Eur J Clin Microbiol; 1984 Aug; 3(4):282-4. PubMed ID: 6208021
    [No Abstract]   [Full Text] [Related]  

  • 15. The interferon system as a basis for antiviral therapy or prophylaxis.
    Billiau A
    Antiviral Res; 1985; Suppl 1():131-40. PubMed ID: 3936410
    [No Abstract]   [Full Text] [Related]  

  • 16. The future of antiviral chemotherapy.
    Crowe S; Mills J
    Dermatol Clin; 1988 Oct; 6(4):521-37. PubMed ID: 3067915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for new antiviral agents.
    Freestone DS
    Antiviral Res; 1985 Dec; 5(6):307-24. PubMed ID: 3004326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon.
    Monto AS; Albrecht JK; Schwartz SA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):47-50. PubMed ID: 2831814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families.
    Monto AS; Schwartz SA; Albrecht JK
    Antimicrob Agents Chemother; 1989 Mar; 33(3):387-90. PubMed ID: 2543280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral chemotherapy and prophylaxis of viral respiratory disease.
    Sperber SJ; Hayden FG
    Clin Lab Med; 1987 Dec; 7(4):869-96. PubMed ID: 2446820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.